TickerFactsScreenerDevelopers

AIM ImmunoTech Inc. (AIM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $6.12M2009: $58.07M2010: $2.92M2011: $3.10M2012: $2.21M2013: $803.0K2014: $2.16M2015: $2.12M2016: $2.41M2017: $1.41M2018: $299.0K2019: $1.47M2020: $38.50M2021: $32.09M2022: $27.05M2023: $5.44M2024: $1.70M2025: $2.98M$2.98M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.98M+75.5%
2024$1.70M-68.7%
2023$5.44M-79.9%
2022$27.05M-15.7%
2021$32.09M-16.6%
2020$38.50M+2519.1%
2019$1.47M+391.6%
2018$299.0K-78.8%
2017$1.41M-41.4%
2016$2.41M+13.9%
2015$2.12M-1.9%
2014$2.16M+168.5%
2013$803.0K-63.7%
2012$2.21M-28.7%
2011$3.10M+6.3%
2010$2.92M-95.0%
2009$58.07M+849.0%
2008$6.12M—